Advanced Search

    column
    Targeted Therapy: New Problems, New Exploratio
    WU Yi-long, SUN Yan, WANG Chang-li, LIAO Mei-lin, ZHOU Qing-hua, LU Shun, CHENG Ying, ZHOU Cai-cun, WANG Jie, ZHANG Li, CHEN Xiao-yuan, MAO Wei-min, JIANG Guo-liang, WANG Jun, WANG Qun, FENG Ji-feng, FU Xiao-long, YU Ding, HUANG Cheng, LIANG Jun, YU Shi-ying, MA Sheng-lin, YANG Jin-ji, XU Chong-rui
    2015, 15(4): 193-197. DOI: 10.3969/j.issn.1671-5144.2015.04.001
    Abstract FullText HTML PDF
    An Interview at 2015 Chinese Lung Cancer Summit Forum
    YU Lin, ZHANG Hua
    2015, 15(4): 198-205. DOI: 10.3969/j.issn.1671-5144.2015.04.002
    Abstract FullText HTML PDF
    Ten Years of A Sword
    WU Yi-long
    2015, 15(4): 206-207. DOI: 10.3969/j.issn.1671-5144.2015.04.003
    Abstract FullText HTML PDF
    Safety and Activity, AZD9291 and Rociletinib in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer
    TU Hai-yan
    2015, 15(4): 208-209. DOI: 10.3969/j.issn.1671-5144.2015.04.004
    Abstract FullText HTML PDF
    Cumulative Incidence and Mortality of Esophageal Squamous Cell Carcinoma Declines due to One-Time Endoscopic Screening
    WANG Meng, QIAO You-lin
    2015, 15(4): 210-210. DOI: 10.3969/j.issn.1671-5144.2015.04.005
    Abstract FullText HTML PDF
    The Present and Future of Lung Cancer Immune Check-Point Treatment
    JIANG Ben-yuan, WU Yi-long
    2015, 15(4): 211-212. DOI: 10.3969/j.issn.1671-5144.2015.04.006
    Abstract FullText HTML PDF
    Activity and Safety, An Anti-PD-1 Immune Checkpoint Inhibitor, for Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
    CHEN Xi, ZHOU Jian-ying, LI Yang-si
    2015, 15(4): 213-216. DOI: 10.3969/j.issn.1671-5144.2015.04.007
    Abstract FullText HTML PDF
    Association of PD-L1 Overexpression with Activating EGFR Mutations in Surgically Resected Non-Small Cell Lung Cancer
    LIU Xiao-qing, HUANG Shu-mei
    2015, 15(4): 217-221. DOI: 10.3969/j.issn.1671-5144.2015.04.008
    Abstract FullText HTML PDF
    The Correlation between Lung Cancer Mutation Spectrum and Immune Efficacy
    ZHONG Wen-zhao, ZHAI Hao-ran
    2015, 15(4): 222-224. DOI: 10.3969/j.issn.1671-5144.2015.04.009
    Abstract FullText HTML PDF
    Nivolumab Versus Docetaxel in Advanced Squamous-Cell Non-Small Cell Lung Cancer
    LU Shun, YU Yong-feng, ZHANG Yi-chen
    2015, 15(4): 225-227. DOI: 10.3969/j.issn.1671-5144.2015.04.010
    Abstract FullText HTML PDF
    Tumors with Mismatch-Repair Deficiency Improve the Clinical Efficacy of Anti-PD-1 Immunotherapy
    XIONG Bin, DONG Zhong-yi
    2015, 15(4): 228-231. DOI: 10.3969/j.issn.1671-5144.2015.04.011
    Abstract FullText HTML PDF
    Analysis of Serum Enzymes in Healthy Children and Adolescents by Dry Chemical System
    LUO Xiao-juan, CAO Ke, MA Dong-li, LIU Xin-gang, HUANG Bao-xing, CHEN Yun-sheng
    2015, 15(4): 232-235. DOI: 10.3969/j.issn.1671-5144.2015.04.012
    Abstract FullText HTML PDF
    Diagnostic Value Analysis of Serum NSE, CEA, CYFRA21-1 for Lung Cancer Based on ROC Curve and Logistic Regression
    DI Yu-wei, YANG Xia, DUAN Wei, LIANG Min-wen, LI Zheng-kang, DONG Hui
    2015, 15(4): 237-240. DOI: 10.3969/j.issn.1671-5144.2015.04.013
    Abstract FullText HTML PDF
    Clinical Characteristics of Patients Hospitalized Again with Gastrointestinal Bleeding and Receiving Dual Antiplatelet Treatment after PCI
    WANG Ling, LI Wei, LUO Jian-fang, LUO Song-yuan, CHEN Ji-yan
    2015, 15(4): 242-246. DOI: 10.3969/j.issn.1671-5144.2015.04.014
    Abstract FullText HTML PDF
    Introduction to Cumulative Meta-Analysis and Application of CMA Software
    LI Guo-chun
    2015, 15(4): 247-251. DOI: 10.3969/j.issn.1671-5144.2015.04.015
    Abstract FullText HTML PDF
    The Multimodality Therapy for Locally-Advanced Nasopharyngeal Carcinoma
    YANG Li-hui, ZHENG Deng-yun
    2015, 15(4): 252-256. DOI: 10.3969/j.issn.1671-5144.2015.04.016
    Abstract FullText HTML PDF